Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$5.37 - $8.35 $63,188 - $98,254
-11,767 Reduced 38.97%
18,427 $130,000
Q4 2023

Feb 13, 2024

BUY
$4.44 - $6.7 $134,061 - $202,299
30,194 New
30,194 $202,000
Q2 2023

Aug 14, 2023

BUY
$4.36 - $6.2 $55,781 - $79,322
12,794 New
12,794 $70,000
Q4 2022

Feb 14, 2023

SELL
$4.06 - $5.71 $98,978 - $139,204
-24,379 Reduced 39.31%
37,632 $175,000
Q2 2022

Aug 08, 2022

BUY
$5.84 - $20.02 $362,144 - $1.24 Million
62,011 New
62,011 $367,000
Q1 2022

May 16, 2022

SELL
$13.62 - $32.45 $183,583 - $437,393
-13,479 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$32.11 - $47.16 $432,810 - $635,669
13,479 New
13,479 $440,000
Q2 2021

Aug 12, 2021

SELL
$28.27 - $41.18 $196,108 - $285,665
-6,937 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$35.03 - $56.99 $243,003 - $395,339
6,937 New
6,937 $263,000

Others Institutions Holding GDRX

About GoodRx Holdings, Inc.


  • Ticker GDRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 84,394,800
  • Market Cap $409M
  • Description
  • GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated pri...
More about GDRX
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.